Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

Peter Dutton wants to break up insurers and investors are fearful, but should they be?

By Nick Sundich | February 20, 2025

Some investors are worried that Peter Dutton wants to break up insurers. Not just because he is in with a chance at the forthcoming federal election, but his ambitions appear legitimate. You cannot say at least some investors are worried – Suncorp (ASX:SUN) fell over 20% in a single day earlier this week. How legitimate…

Read More

Is Lendlease (ASX:LLC) out of the doldrums for good?

By Nick Sundich | February 20, 2025

Lendlease (ASX:LLC) has for the past several years been the classic definition of a ‘value trap’. You think a good company is trading at a bargain price due to a ‘temporary setback’, but the setback turns out to be a lot more than temporary or just the tip of the iceberg. If you bought Lendlease…

Read More

ASX Futures in 2025: Riding the Wave or Getting Wiped Out? A Practical Guide for New Traders

By Ujjwal Maheshwari | February 19, 2025

New traders will encounter both risks and opportunities when trading ASX futures contracts on the Australian Securities Exchange in 2025. Modern traders need a solid understanding of ASX futures to succeed in markets that show volatile behaviour as the global economy returns to normal. This guide aims to provide practical information to help novice traders…

Read More

Recce’s R327G passed its Phase 2 trial with a 93% primary efficiacy endpoint!

By Nick Sundich | February 19, 2025

Recce Pharmaceuticals (ASX:RCE) has completed its Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections) for RECCE® 327 Topical Gel (R327G) and released the results earlier this week. The results were positive, and pave the way for commercialisation as early as 2026.   How Recce got to this point Recce is a biotech…

Read More

Cochlear (ASX:COH) is still a long term growth story you should listen to

By Nick Sundich | February 19, 2025

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of its users. Yes, this can be said with respect to many ASX health stocks, but this one can hang its hat on its societal impacts more than most other companies. The stock has seen a…

Read More

So your company just unveiled unaudited results for FY25? Are they accurate and how much weight should I place on them?

By Nick Sundich | February 19, 2025

It is reporting season soon but unaudited results are being released ahead of that by many companies and some have even done so throughout the financial year. How much weight should you place on unaudited results as an investor? Let’s take a look at that question.   Unaudited results – what are they? Audited results…

Read More

ASX Stocks to buy when interest rates fall: Here are our top 3 sectors

By Nick Sundich | February 18, 2025

Many investors are asking what ASX Stocks to buy when interest rates fall. When exactly interest rates will fall is anyone’s guess, until earlier today (February 18, 2025) when rates were cut from 4.35% to 4.1%. Argue all you like about whether the RBA could’ve gone further or should’ve stayed put, but it did what…

Read More

Why investors are excited about Chalice’s Gonneville/Julimar project once again and if they’re getting ahead of themselves

By Nick Sundich | February 18, 2025

Chalice Mining (ASX:CHN) shares climbed over 10% yesterday after an announcement declaring a ‘major metallurgical breakthrough at Gonneville’. Investors liked the look of this, but is this just a temporary reprieve from some of their worries, or is it a game-changer?   Gonneville/Julimar: The discovery of the decade Gonneville is a deposit at Chalice’s Julimar…

Read More

Here’s why value investing went out of vogue and if investors will ever bother with it again

By Nick Sundich | February 18, 2025

‘Value investing is dead!’ many have proclaimed. This is not entirely accurate, but there is little doubt that the strategy that built the empire of Warren Buffett and Charlie Munger has gone out of vogue. But to say it has gone out of vogue is different from saying the strategy is dead. So let’s take…

Read More

6 of the best places to get Stock Market Information from in Australia!

By Nick Sundich | February 17, 2025

6 of the best places to get Stock Market Information from in Australia! The ASX website Yes this is obvious, but we had to include it anyway. This is where all companies will post their announcements and so it is the best place to go for them. You could get the same information from external…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Battery Age Minerals (ASX: BM8) expands its portfolio with a gold and silver project

Battery Age Minerals (ASX:BM8) We spoke to Nigel Broomham, CEO of Battery Age Minerals (ASX: BM8)…

Nanoveu’s Edge AI chip is set for a big 2025: Interview with Semiconductor CEO Mark Goranson

Nanoveu (ASX:NVU) We spoke with Mark Goranson, the new CEO of Nanoveu’s (ASX:NVU) Semiconductor Division. NVU…

Moab Minerals (ASX:MOM): Interview with MD Malcolm Day

Moab Minerals (ASX:MOM) We spoke with Malcolm Day, Managing Director of Moab Minerals (ASX:MOM), about the…

Titan Minerals (ASX:TTM) interview with CEO Melanie Leighton

Titan Minerals (ASX:TTM) We spoke to Melanie Leighton, CEO of Titan Minerals (ASX: TTM), about the…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.